ATE302601T1 - Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten - Google Patents

Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten

Info

Publication number
ATE302601T1
ATE302601T1 AT01927346T AT01927346T ATE302601T1 AT E302601 T1 ATE302601 T1 AT E302601T1 AT 01927346 T AT01927346 T AT 01927346T AT 01927346 T AT01927346 T AT 01927346T AT E302601 T1 ATE302601 T1 AT E302601T1
Authority
AT
Austria
Prior art keywords
benzamide
treatment
compositions containing
disulfide derivative
allergy diseases
Prior art date
Application number
AT01927346T
Other languages
English (en)
Inventor
Steven T Miller
Mark R Hellberg
Zixia Feng
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE302601T1 publication Critical patent/ATE302601T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT01927346T 2000-05-19 2001-04-25 Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten ATE302601T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20608300P 2000-05-19 2000-05-19
PCT/US2001/013399 WO2001089493A2 (en) 2000-05-19 2001-04-25 Compositions containing a benzamide disulfide derivative for treating allergic diseases

Publications (1)

Publication Number Publication Date
ATE302601T1 true ATE302601T1 (de) 2005-09-15

Family

ID=22764902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01927346T ATE302601T1 (de) 2000-05-19 2001-04-25 Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten

Country Status (19)

Country Link
US (1) US6492418B2 (de)
EP (1) EP1284722B1 (de)
JP (1) JP2003534274A (de)
KR (1) KR20020093981A (de)
CN (1) CN1172666C (de)
AR (1) AR029085A1 (de)
AT (1) ATE302601T1 (de)
AU (2) AU5380701A (de)
BR (1) BR0110852A (de)
CA (1) CA2407767A1 (de)
DE (1) DE60112922T2 (de)
DK (1) DK1284722T3 (de)
ES (1) ES2243482T3 (de)
HK (1) HK1049614B (de)
MX (1) MXPA02011482A (de)
PL (1) PL363102A1 (de)
PT (1) PT1284722E (de)
WO (1) WO2001089493A2 (de)
ZA (1) ZA200208838B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020093982A (ko) * 2000-05-19 2002-12-16 알콘, 인코퍼레이티드 알레르기성 질환 치료를 위한 아닐린 디설파이드 유도체
CN1976694A (zh) * 2004-06-28 2007-06-06 爱尔康公司 用于治疗变应性疾病的局部用制剂
KR100984814B1 (ko) * 2009-12-21 2010-10-01 삼성전자주식회사 수평형 사출 금형 시스템 및 이를 이용하는 사출 성형 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (de) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0000627B1 (de) * 1977-07-09 1982-09-01 Michael Fred Joyce Träger für Behälter, Vorrichtung und Verfahren zu deren Anbringen an Behältern
JPS55324A (en) * 1978-06-16 1980-01-05 Kyowa Hakko Kogyo Co Ltd Antithrombotic
EP0006227B1 (de) 1978-06-16 1984-12-27 Kyowa Hakko Kogyo Co., Ltd 2,2'-Dithiobis-benzamidderivate enthaltende antithrombische pharmazeutische Präparate und 2,2'-Dithiobis-benzamidderivate
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
ZA200208838B (en) 2003-10-31
DE60112922D1 (de) 2005-09-29
DE60112922T2 (de) 2006-01-26
AR029085A1 (es) 2003-06-04
HK1049614A1 (en) 2003-05-23
DK1284722T3 (da) 2005-09-19
US20020065281A1 (en) 2002-05-30
ES2243482T3 (es) 2005-12-01
HK1049614B (zh) 2005-11-18
US6492418B2 (en) 2002-12-10
CN1172666C (zh) 2004-10-27
KR20020093981A (ko) 2002-12-16
AU5380701A (en) 2001-12-03
PL363102A1 (en) 2004-11-15
EP1284722A2 (de) 2003-02-26
EP1284722B1 (de) 2005-08-24
JP2003534274A (ja) 2003-11-18
AU2001253807B2 (en) 2005-02-17
WO2001089493A3 (en) 2002-03-28
PT1284722E (pt) 2005-10-31
CA2407767A1 (en) 2001-11-29
CN1429107A (zh) 2003-07-09
WO2001089493A2 (en) 2001-11-29
BR0110852A (pt) 2003-02-11
MXPA02011482A (es) 2003-06-06

Similar Documents

Publication Publication Date Title
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60233069D1 (de) Zusammensetzungen aus curcuma extrakten für die behandlung von neurozerebrovaskulären erkrankungen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
DE60329123D1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
FIU20060389U0 (fi) Luusairauksien hoito
ATE494279T1 (de) Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60124576D1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
DE60239218D1 (de) Synergistische zusammensetzungen für die behandlung von saatgut
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60216457D1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE272619T1 (de) Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
ATE330938T1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1284722

Country of ref document: EP

REN Ceased due to non-payment of the annual fee